Peter Leigh
Cited by
Cited by
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
J Sreedharan, IP Blair, VB Tripathi, X Hu, C Vance, B Rogelj, S Ackerley, ...
Science 319 (5870), 1668-1672, 2008
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6
C Vance, B Rogelj, T Hortobágyi, KJ De Vos, AL Nishimura, J Sreedharan, ...
Science 323 (5918), 1208-1211, 2009
Amyotrophic lateral sclerosis
LC Wijesekera, P Nigel Leigh
Orphanet journal of rare diseases 4, 1-22, 2009
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.
L Lacomblez, G Bensimon, PN Leigh, P Guillet, V Meininger
Lancet (London, England) 347 (9013), 1425-1431, 1996
Fronto-striatal cognitive deficits at different stages of Parkinson's disease
AM Owen, M James, PN Leigh, BA Summers, CD Marsden, NP Quinn, ...
Brain 115 (6), 1727-1751, 1992
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
MR Turner, A Cagnin, FE Turkheimer, CCJ Miller, CE Shaw, DJ Brooks, ...
Neurobiology of disease 15 (3), 601-609, 2004
Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis
MJ Strong, GM Grace, M Freedman, C Lomen-Hoerth, S Woolley, ...
Amyotrophic Lateral Sclerosis 10 (3), 131-146, 2009
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ...
Nature genetics 48 (9), 1043-1048, 2016
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
CAD Smith, CR Wolf, AC Gough, NK Spurr, PN Leigh, BA Summers, ...
The Lancet 339 (8806), 1375-1377, 1992
Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS)
S Abrahams, PN Leigh, A Harvey, GN Vythelingum, D Grise, LH Goldstein
Neuropsychologia 38 (6), 734-747, 2000
Biomarkers in amyotrophic lateral sclerosis
MR Turner, MC Kiernan, PN Leigh, K Talbot
The Lancet Neurology 8 (1), 94-109, 2009
Diffusion tensor MRI assesses corticospinal tract damage in ALS
CM Ellis, A Simmons, DK Jones, J Bland, JM Dawson, MA Horsfield, ...
Neurology 53 (5), 1051-1051, 1999
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
A Al-Chalabi, PM Andersen, P Nilsson, B Chioza, JL Andersson, C Russ, ...
Human molecular genetics 8 (2), 157-164, 1999
Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content
KJ De Vos, AL Chapman, ME Tennant, C Manser, EL Tudor, KF Lau, ...
Human molecular genetics 16 (22), 2720-2728, 2007
Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis
RA Lyall, N Donaldson, MI Polkey, PN Leigh, J Moxham
Brain 124 (10), 2000-2013, 2001
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis
MA Van Es, JH Veldink, CGJ Saris, HM Blauw, PWJ van Vught, A Birve, ...
Nature genetics 41 (10), 1083-1087, 2009
Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis: morphology, distribution, and specificity
PN Leigh, H Whitwell, O Garofalo, J Buller, M Swash, JE Martin, JM Gallo, ...
Brain 114 (2), 775-788, 1991
A proposed staging system for amyotrophic lateral sclerosis
JC Roche, R Rojas-Garcia, KM Scott, W Scotton, CE Ellis, R Burman, ...
Brain 135 (3), 847-852, 2012
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study
A Al-Chalabi, A Calvo, A Chio, S Colville, CM Ellis, O Hardiman, ...
The Lancet Neurology 13 (11), 1108-1113, 2014
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
GD Borasio, W Robberecht, PN Leigh, J Emile, RJ Guiloff, F Jerusalem, ...
Neurology 51 (2), 583-586, 1998
The system can't perform the operation now. Try again later.
Articles 1–20